Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2004;329:754-755 (2 October), doi:10.1136/bmj.329.7469.754
Regular monitoring is necessary only in some situations
| The first 150 words of the full text of this article appear below. |
Diabetes UK, the leading charity for people with diabetes in the United Kingdom, issued the following position statement in July 2003.1 "People with diabetes should have access to home blood glucose monitoring based on individual clinical need, informed consent and not on ability to pay. Home monitoring is essential in the context of diabetes education for self-management in order to enable the person to make appropriate treatment or lifestyle choices." The first part of this statement is not contentious, and most people would probably agree that people with type 1 or type 2 diabetes treated with insulin should regularly monitor blood glucose, not only to guide insulin doses but also to detect and avoid hypoglycaemia. However, is home blood glucose monitoring necessary for people with type 2 diabetes treated with oral hypoglycaemic agents and dietary modification?
Home blood glucose monitoring is a big business. The main profit for the manufacturing
Rebecca M Reynolds, clinical lecturer
Endocrinology Unit, School of Molecular and Clinical Medicine, University of Edinburgh, Edinburgh EH4 2XU
Mark W J Strachan, consultant physician
Metabolic Unit, Western General Hospital, Edinburgh EH4 2XU (mark.strachan@luht.scot.nhs.uk)
Read all Rapid Responses
UK medical students have published unreleased government plans to restrict failed asylum seekers' access to medical care